Published in Eye (Lond) on July 07, 2006
Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review. Graefes Arch Clin Exp Ophthalmol (2012) 1.49
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2010) 1.14
Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol (2010) 1.07
Alterations in the intraocular cytokine milieu after intravitreal bevacizumab. Invest Ophthalmol Vis Sci (2009) 1.01
Vitreous inflammatory factors in macular edema with central retinal vein occlusion. Jpn J Ophthalmol (2011) 0.98
Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study. J Inflamm (Lond) (2010) 0.97
Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion. Clin Interv Aging (2016) 0.96
Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Graefes Arch Clin Exp Ophthalmol (2010) 0.92
Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion. PLoS One (2013) 0.88
[Cytokine determination from vitreous samples in retinal vascular diseases]. Ophthalmologe (2013) 0.85
Proteomics of vitreous humor of patients with exudative age-related macular degeneration. PLoS One (2014) 0.85
Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series. BMC Ophthalmol (2010) 0.85
Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion. Biomed Res Int (2013) 0.84
Visual acuity following intravitreal bevacizumab for macular edema associated with retinal vein occlusion. Jpn J Ophthalmol (2010) 0.84
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results. Clin Ophthalmol (2011) 0.83
Outcomes of microincision vitrectomy surgery with internal limiting membrane peeling for macular edema secondary to branch retinal vein occlusion. Clin Ophthalmol (2015) 0.82
Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion. Int Ophthalmol (2012) 0.80
Pronerve growth factor induces angiogenesis via activation of TrkA: possible role in proliferative diabetic retinopathy. J Diabetes Res (2013) 0.80
Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema. Doc Ophthalmol (2011) 0.79
Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel. Br J Ophthalmol (2014) 0.79
Early Avastin management in acute retinal vein occlusion. Saudi J Ophthalmol (2010) 0.79
Intravitreal vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol (2014) 0.78
Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion. J Ophthalmol (2016) 0.78
Efficacy and Safety in Retinal Vein Occlusion Treated with at Least Three Consecutive Intravitreal Dexamethasone Implants. J Ophthalmol (2016) 0.78
Intracameral concentrations of the fibrinolytic system components in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2013) 0.78
The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases. Mediators Inflamm (2014) 0.77
Visual prognostic value of photopic negative response and optical coherence tomography in central retinal vein occlusion after anti-VEGF treatment. Doc Ophthalmol (2013) 0.77
Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration. J Ophthalmol (2014) 0.77
Influence of ischemia on visual function in patients with branch retinal vein occlusion and macular edema. Clin Ophthalmol (2011) 0.77
Visual function and serous retinal detachment in patients with branch retinal vein occlusion and macular edema: a case series. BMC Ophthalmol (2011) 0.77
Paracrine potential of fibroblasts exposed to cigarette smoke extract with vascular growth factor induction. Laryngoscope (2013) 0.77
Foveal sensitivity and morphology in major and macular branch retinal vein occlusion. Open Ophthalmol J (2012) 0.77
Inflammation in retinal disease. Int J Inflam (2013) 0.77
Photopic negative response in branch retinal vein occlusion with macular edema. Int Ophthalmol (2014) 0.77
Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization. J Ophthalmol (2013) 0.77
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab. Indian J Ophthalmol (2015) 0.76
Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion. Clin Ophthalmol (2013) 0.75
Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion. Korean J Ophthalmol (2017) 0.75
Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials. Clin Ophthalmol (2016) 0.75
Retinal microvascular network and microcirculation assessments in high myopia. Am J Ophthalmol (2016) 0.75
Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment. Sci Rep (2016) 0.75
Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration. Int J Retina Vitreous (2017) 0.75
Intraocular cytokines in retinal vein occlusion and its relation to the efficiency of anti-vascular endothelial growth factor therapy. Indian J Ophthalmol (2015) 0.75
New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion. J Ophthalmol (2017) 0.75
Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology. BMC Ophthalmol (2012) 0.75
Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments. Clin Ophthalmol (2016) 0.75
Intravitreal bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case report. Cases J (2009) 0.75
Changes of macular sensitivity and morphology after pars plana vitrectomy for macular edema with central retinal vein occlusion: a case series. BMC Ophthalmol (2013) 0.75
[Intravitreal fibrinolysis and retinal vein occlusion]. Ophthalmologe (2015) 0.75
Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion. Korean J Ophthalmol (2017) 0.75
Influence of vitreous factors after vitrectomy for macular edema in patients with central retinal vein occlusion. Int Ophthalmol (2011) 0.75
Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion. Int Ophthalmol (2013) 0.75
Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. Br Med J (Clin Res Ed) (1981) 8.77
EIN2, a bifunctional transducer of ethylene and stress responses in Arabidopsis. Science (1999) 7.91
Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature (1997) 6.73
Fgf10 is essential for limb and lung formation. Nat Genet (1999) 5.76
Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest (1998) 4.94
Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell (1993) 3.57
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem (1994) 3.49
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet (2001) 3.21
Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun (1990) 3.17
FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun (2000) 3.08
Characterization of type I receptors for transforming growth factor-beta and activin. Science (1994) 2.94
Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology (2004) 2.76
A gene encoding a mitogen-activated protein kinase kinase kinase is induced simultaneously with genes for a mitogen-activated protein kinase and an S6 ribosomal protein kinase by touch, cold, and water stress in Arabidopsis thaliana. Proc Natl Acad Sci U S A (1996) 2.72
A transmembrane hybrid-type histidine kinase in Arabidopsis functions as an osmosensor. Plant Cell (1999) 2.62
Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem (2000) 2.58
An epidemiological study of oral and pharyngeal cancer in Central and South-East Asia. Bull World Health Organ (1966) 2.56
Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis (1998) 2.40
Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A (1999) 2.39
Size and position invariance of neuronal responses in monkey inferotemporal cortex. J Neurophysiol (1995) 2.39
Alpha-amylase genes (amyR2 and amyE+) from an alpha-amylase-hyperproducing Bacillus subtilis strain: molecular cloning and nucleotide sequences. J Bacteriol (1983) 2.36
Cerebral arteriovenous malformations: factors influencing the surgical difficulty and outcome. Neurosurgery (1991) 2.36
The nucleotide sequence of the promoter and the amino-terminal region of alkaline phosphatase structural gene (phoA) of Escherichia coli. Nucleic Acids Res (1981) 2.32
Amnestic people with Alzheimer's disease who remembered the Kobe earthquake. Br J Psychiatry (1998) 2.26
Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs. J Biol Chem (1995) 2.25
Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain. Nature (1995) 2.20
Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol (2000) 2.20
Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A (1995) 2.19
A cytoskeleton-related gene, uso1, is required for intracellular protein transport in Saccharomyces cerevisiae. J Cell Biol (1991) 2.17
Matrix/integrin interaction activates the mitogen-activated protein kinase, p44erk-1 and p42erk-2. J Biol Chem (1995) 2.09
Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction. Surgery (1999) 2.09
Subcutaneous release of trigger thumb and fingers in 210 fingers. J Hand Surg Br (1990) 2.05
Analgesic effect of morphine glucuronides. Tohoku J Exp Med (1971) 2.02
Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA). Br J Cancer (2007) 2.00
A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta (1985) 1.99
Molecular cloning of the protocatechuate 4,5-dioxygenase genes of Pseudomonas paucimobilis. J Bacteriol (1990) 1.95
Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ Res (1998) 1.94
The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. Development (1997) 1.92
Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb Pathog (1987) 1.90
Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol (1989) 1.89
Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res (2005) 1.88
Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol Adv (2009) 1.82
Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes (2001) 1.82
Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb Pathog (1989) 1.78
Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol Adv (2011) 1.78
Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc Natl Acad Sci U S A (1995) 1.78
Comparative epidemiology of cancers of the United States and Japan. Prev Med (1977) 1.77
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol (2009) 1.73
Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology (2000) 1.73
Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem (1996) 1.72
Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology (1999) 1.71
Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology (1990) 1.68
UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell (2005) 1.68
Cancer mortality in nonsmoking women with smoking husbands based on a large-scale cohort study in Japan. Prev Med (1984) 1.67
Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke (1982) 1.67
Characteristics and surgical outcomes of paediatric retinal detachment. Eye (Lond) (2004) 1.66
Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol Biol Cell (2000) 1.66
Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg (2001) 1.65
Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab (1999) 1.65
Gastrointestinal tract perforation: CT diagnosis of presence, site, and cause. Abdom Imaging (2005) 1.63
Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem (2000) 1.61
Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. Microbiol Immunol (1988) 1.61
Crystallization and properties of staphylococcal leukocidin. Biochim Biophys Acta (1980) 1.56
Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM). Paraplegia (1989) 1.55
Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. J Biol Chem (1999) 1.54
[Studies on antispetics for foodstuff. LXXI. Studies on orsellinic acid ester, beta-orcinolcarboxylic acid ester and olivetonide as a preservative for sake]. Yakugaku Zasshi (1970) 1.54
In vitro and in vivo hematopoietic effect of mutant human granulocyte colony-stimulating factor. Blood (1990) 1.54
High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J (2001) 1.53
Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer (2008) 1.53
Cigarette smoking and cancer mortality risk in Japanese men and women--results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect (1990) 1.53
Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol (2001) 1.52
A bacterial enzyme degrading the model lignin compound beta-etherase is a member of the glutathione-S-transferase superfamily. FEBS Lett (1993) 1.52
Chronic intestinal pseudoobstruction associated with autoantibodies against proliferating cell nuclear antigen. Arthritis Rheum (1996) 1.52
Significance of the V-type ATPase for the adaptation to stressful growth conditions and its regulation on the molecular and biochemical level. J Exp Bot (2001) 1.52
Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology (2000) 1.51
Phosphorylation-dependent power output of transgenic flies: an integrated study. Biophys J (1997) 1.50
Relationship between refraction and allergic conjunctivitis. Eye (Lond) (2007) 1.50
Supernumerary head of biceps brachii and branching pattern of the musculocutaneus nerve in Japanese. Surg Radiol Anat (1992) 1.50
Kluyveromyces lactis killer toxin inhibits adenylate cyclase of sensitive yeast cells. Nature (1983) 1.50
Exon-intron organization of the Arabidopsis thaliana protein kinase genes CDC2a and CDC2b. FEBS Lett (1992) 1.49
Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology (1986) 1.48
Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol (2000) 1.48
Neuroprotective mechanism of bromocriptine. Lancet (1995) 1.48
Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb Pathog (1987) 1.47
Cumulus mass maintains embryo quality. Fertil Steril (1994) 1.47
Corticospinal direct response in humans: identification of the motor cortex during intracranial surgery under general anaesthesia. J Neurol Neurosurg Psychiatry (1988) 1.46
Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol. J Biol Chem (1988) 1.45
Pharmacological classification of central post-stroke pain: comparison with the results of chronic motor cortex stimulation therapy. Pain (1997) 1.45
Cloning and sequencing of the gene for a Pseudomonas paucimobilis enzyme that cleaves beta-aryl ether. J Bacteriol (1991) 1.44
Adhesion molecules and inherited diseases of the human nervous system. Annu Rev Neurosci (1998) 1.44
Protruding atherosclerotic aortic plaques and dyslipidaemia: correlation to subtypes of ischaemic stroke. Eur J Echocardiogr (2002) 1.43
Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients. Pharmacopsychiatry (2002) 1.43
Vitamin D receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1990) 1.42
Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids (2001) 1.42
Experimental study of neurotization of denervated muscles with nerve-to-vein transfer. Microsurgery (1991) 1.42